v3.26.1
Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 19 $ 93,785,946 $ (100,556,137) $ (6,770,171)
Balance, shares at Dec. 31, 2024 185,589      
Issuance of Common Stock upon exercise of stock options 1,654 1,654
Issuance of Common Stock upon exercise of stock options, shares 34      
Issuance of Common Stock to Square Gate $ 1 149,999 150,000
Issuance of Common Stock to Square Gate, shares 1,603      
Issuance cost of Common Stock (22,297) (22,297)
Stock-based compensation 275,642 275,642
Net income (loss) (2,196,875) (2,196,875)
Balance at Mar. 31, 2025 $ 20 94,190,944 (102,753,012) (8,562,047)
Balance, shares at Mar. 31, 2025 187,226      
Balance at Dec. 31, 2025 $ 55 111,280,560 (108,515,846) 2,764,769
Balance, shares at Dec. 31, 2025 546,635      
Stock-based compensation 10,019 10,019
Net income (loss) 3,472,480 3,472,480
Common Stock issued in connection with abeyance shares [1] $ 16 (16)
Common Stock issued in connection with abeyance shares, shares 162,834      
Issuance of pre-funded warrants 1,499,753 1,499,753
Exercise of pre-funded warrants $ 41 206 247
Exercise of pre-funded warrants, shares 412,882      
Reclassification of the modified warrant to liability (1,595,778) (1,595,778)
Issuance of Common Stock warrants 1,488,472 1,488,472
Equity dividend to investor (1,488,472) (1,488,472)
Issuance costs of Common Stock warrants (181,198) (181,198)
Issuance costs of pre-funded warrants (207,858) (207,858)
Balance at Mar. 31, 2026 $ 112 $ 110,805,688 $ (105,043,366) $ 5,762,434
Balance, shares at Mar. 31, 2026 1,122,351      
[1] During the three months ended March 31, 2026, 162,834 shares previously held in abeyance were issued and there are no shares in abeyance remaining.